Sam Brusco, Associate Editor01.09.23
Orthofix and SeaSpine have successfully completed their previously announced merger.
It became effective on January 5, under while wholly-owned subsidiary Orthofix Medical Inc. merged with and into SeaSpine, with SeaSpine continuing as the surviving company and a wholly-owned subsidiary of Orthofix.
The combined Orthofix is a global spine and orthopedics company with a portfolio of biologics, spinal hardware solutions, bone-growth therapies, specialized orthopedic solutions, and a surgical navigation system. The company has about 1,600 employees, products distributed in 68 countries, and a global R&D, commercial, and manufacturing footprint.
“The completion of this merger catalyzes our ambition to be an industry leader in spine and orthopedics,” Keith Valentine, president and CEO of Orthofix effective as of the closing told the press. “I’m privileged to lead this talented team and excited for all of the opportunities that lie ahead. Together we are stronger and better positioned to deliver innovative, quality-driven solutions for surgeons in their work to improve patients’ lives.”
Jon Serbousek, executive chairman of the combined company’s Board of Directors, said, “With broad, differentiated technologies, extensive commercial reach and a strong financial profile, we expect our combined company to drive meaningful market share gains, sustainable growth and value creation. We look forward to setting new standards of innovation and delivering on the many benefits we expect to provide for our shareholders, surgeons and employees.”
Previously announced members of the combined company’s executive leadership team include:
It became effective on January 5, under while wholly-owned subsidiary Orthofix Medical Inc. merged with and into SeaSpine, with SeaSpine continuing as the surviving company and a wholly-owned subsidiary of Orthofix.
The combined Orthofix is a global spine and orthopedics company with a portfolio of biologics, spinal hardware solutions, bone-growth therapies, specialized orthopedic solutions, and a surgical navigation system. The company has about 1,600 employees, products distributed in 68 countries, and a global R&D, commercial, and manufacturing footprint.
“The completion of this merger catalyzes our ambition to be an industry leader in spine and orthopedics,” Keith Valentine, president and CEO of Orthofix effective as of the closing told the press. “I’m privileged to lead this talented team and excited for all of the opportunities that lie ahead. Together we are stronger and better positioned to deliver innovative, quality-driven solutions for surgeons in their work to improve patients’ lives.”
Jon Serbousek, executive chairman of the combined company’s Board of Directors, said, “With broad, differentiated technologies, extensive commercial reach and a strong financial profile, we expect our combined company to drive meaningful market share gains, sustainable growth and value creation. We look forward to setting new standards of innovation and delivering on the many benefits we expect to provide for our shareholders, surgeons and employees.”
Previously announced members of the combined company’s executive leadership team include:
- Suzanne Armstrong, Chief Human Resources Officer
- John Bostjancic, Chief Financial Officer
- Roberto Donadello, Senior Vice President, Global Operations
- Kim Elting, President, Global Orthopedics
- Ehab Esmail, Senior Vice President, Global Quality, Regulatory and Clinical Affairs
- Kevin Kenny, President, Global Spine
- Patrick Keran, Chief Legal Officer
- Tyler Lipschultz, President, Global Biologics
- Beau Standish, President, Global Enabling Technologies
